NCT00448903

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

Multicentric, Randomized, Double-blind, Controlled Clinical Trial to Assess the Efficacy and Safety of Bemiparin Sodium as Treatment of Diabetic Foot Ulcers

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 329 (actual)
• Sponsor: Rovi Pharmaceuticals Laboratories · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Chronic foot ulcers are a common, severe and expensive complication in patients with diabetes and often causes lower-extremity amputation. The aim of this study is to evaluate the effect of bemiparin as treatment of diabetic foot ulcers.

Conditions

• Foot Ulcer, Diabetic

Interventions

Type	Name	Description
DRUG	Bemiparin	Bemiparin sodium
DRUG	Placebo	Sodium Chloride 0,9%

Timeline

• Start date: 2007-03-01
• Primary completion: 2009-12-01
• Completion: 2010-04-01
• First posted: 2007-03-19
• Last updated: 2011-03-17

Locations

6 sites across 6 countries: Croatia, Poland, Romania, Russia, Serbia, Spain